Joseph A O'Donoghue

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph A O'Donoghue, Pat B Zanzonico, John Laurence Humm, Adam Leon Kesner
Reply LTE: Dosimetry in Radiopharmeceutical Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2022)
Simone Krebs, Christian Grommes, Michael R McDevitt, Sean D Carlin, Joseph A O'Donoghue, Maya Srikanth Graham, Robert J Young, Heiko Schöder, Philip H Gutin, Neil H Bander, Joseph R Osborne
[89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma. European journal of nuclear medicine and molecular imaging (2021)
Gary A Ulaner, Nicholas B Sobol, Joseph A O'Donoghue, Assen S Kirov, Christopher C Riedl, Ryan Min, Eric Smith, Lukas Michael Carter, Serge K Lyashchenko, Jason S Lewis, Carl Ola Landgren
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging. Radiology 295 (3) (2020)
Heiko Schöder, Paula Demétrio De Souza França, Reiko Nakajima, Eva Burnazi, Sheryl Roberts, Christian Brand, Milan Grkovski, Audrey Mauguen, Mark P Dunphy, Ronald A Ghossein, Serge K Lyashchenko, Jason S Lewis, Joseph A O'Donoghue, Ian Ganly, Snehal G Patel, Nancy Y Lee, Thomas Reiner
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (13) (2020)
Christian Lohrmann, Eileen M O'Reilly, Joseph A O'Donoghue, Neeta Pandit-Taskar, Jorge A Carrasquillo, Serge K Lyashchenko, Shutian Ruan, Rebecca Teng, Wolfgang Scholz, Paul W Maffuid, Jason S Lewis, Wolfgang A Weber
Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (23) (2019)